Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Witt (München, Germany), J. Waelscher (Heidelberg, Germany), L. Schwarzkopf (München, Germany), M. Kreuter (Heidelberg, Germany). Hospitalisation pattern in Interstitial Lung Diseases: a claims data study. 2909

Member's Comments

No comment yet.

Related content which might interest you: Romanian Registry for Interstitial Lung Diseases (REGIS): inclusion of patients in 3 years Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST) Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings Year: 2018 Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017 The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Gender perspective in Interstitial Lung Diseases (ILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Multicenter Registry of Interstitial Lung Diseases in Brazil Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 DANILDA – The First Danish National Interstitial Lung Disease Registry Source: International Congress 2019 – Interstitial lung disease registries Year: 2019 The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Evaluation of three dyspnea questionnaires in the progression of Interstitial Lung Diseases. Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 The Severe Asthma Registry – German data Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Consequences of Lung Cancer: Mortality and Comorbidity in Danish Patients with Lung Cancer 1998-2010 Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Causes of Hospitalization and Mortality in Lung Cancer Patients Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease Source: Breathe 2014; 10:173-175 Year: 2014 ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly Source: ERJ Open Res, 6 (4) 00143-2020; 10.1183/23120541.00143-2020 Year: 2020 Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference? Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 Rare diseases registries such as the Rare Lung Disease Registry Data Warehouse Source: International Congress 2018 – Rare lung diseases Year: 2018